Karyopharm Therapeutics Inc.（KPTI）内部人交易：高管与董事近期交易
过去 18 个月，共有 13 位内部人为 Karyopharm Therapeutics Inc.（KPTI）报告了 63 笔 Form 4 交易（最近一笔 2026-10-02）。
| 日期 | 内部人 | 职务 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-10-02 | Abate Kristin | Chief Accounting Officer | 卖出 | 378 | $450 |
| 2026-09-02 | Abate Kristin | Chief Accounting Officer | 卖出 | 19 | $38 |
| 2026-07-30 | Poulton Stuart | EVP, Chief Development Officer | 卖出 | 189 | $1,342 |
| 2026-05-26 | PAKIANATHAN DEEPIKA | 董事 | 买入 | 15,508 | $0 |
| 2026-05-26 | BOHLIN GAREN G | 董事 | 买入 | 15,508 | $0 |
| 2026-05-26 | Oliger Christy J. | 董事 | 买入 | 15,508 | $0 |
| 2026-05-26 | Schor Chen | 董事 | 买入 | 15,508 | $0 |
| 2026-05-26 | Su Zhen | 董事 | 买入 | 15,508 | $0 |
| 2026-05-26 | Greene Barry E | 董事 | 买入 | 15,508 | $0 |
| 2026-05-15 | Rangwala Reshma | EVP & Chief Medical Officer | 卖出 | 408 | $3,876 |
| 2026-05-15 | Poulton Stuart | EVP, Chief Development Officer | 卖出 | 403 | $3,828 |
| 2026-05-15 | Rangwala Reshma | EVP & Chief Medical Officer | 买入 | 947 | $0 |
| 2026-05-15 | Poulton Stuart | EVP, Chief Development Officer | 买入 | 896 | $0 |
| 2026-05-15 | Cheng Sohanya Roshan | EVP & Chief Commercial Officer | 买入 | 947 | $0 |
| 2026-05-15 | Cheng Sohanya Roshan | EVP & Chief Commercial Officer | 卖出 | 324 | $3,078 |
| 2026-05-15 | Paulson Richard A. | President and CEO | 买入 | 4,920 | $0 |
| 2026-05-15 | Paulson Richard A. | President and CEO | 卖出 | 2,203 | $20,928 |
| 2026-05-15 | Mano Michael | EVP, CLO&Secretary | 买入 | 700 | $0 |
| 2026-05-15 | Mano Michael | EVP, CLO&Secretary | 卖出 | 266 | $2,527 |
| 2026-05-15 | Abate Kristin | Chief Accounting Officer | 买入 | 121 | $0 |
| 2026-05-15 | Abate Kristin | Chief Accounting Officer | 卖出 | 53 | $504 |
| 2026-04-22 | Rangwala Reshma | EVP & Chief Medical Officer | 卖出 | 449 | $4,014 |
| 2026-03-03 | Cheng Sohanya Roshan | EVP & Chief Commercial Officer | 卖出 | 4,604 | $43,324 |
| 2026-03-03 | Rangwala Reshma | EVP & Chief Medical Officer | 卖出 | 5,066 | $47,671 |
| 2026-03-03 | Abate Kristin | Chief Accounting Officer | 卖出 | 559 | $5,260 |
来源：SEC Form 4 申报文件 · 截至 2026-10-02